MITOS Receives LVT Certification: A Testament to Excellence in Breast Cancer Detection Technology

We are thrilled to announce that MITOS has been awarded the LVT (Low Voltage Directive) certification, a significant achievement that underscores our commitment to delivering cutting-edge medical devices for breast cancer detection.

The LVT certification, in compliance with the European Union's standards, is a testament to MITOS's dedication to upholding the highest quality and safety standards in the development and manufacturing of our medical devices.

This certification is a result of MITOS's unwavering focus on research and innovation in the field of breast cancer detection technology. It signifies our ability to meet the rigorous requirements set forth by regulatory bodies, ensuring that our products are not only effective but also safe for clinical use.

The LVT certification further solidifies MITOS's position as a leader in the medical device industry, showcasing our commitment to excellence and our dedication to providing healthcare professionals and patients with reliable and innovative solutions.

We are proud to have achieved this milestone, and we remain committed to advancing the field of breast cancer detection through our continued research, development, and dedication to excellence.

Stay tuned for more updates as we continue to innovate and strive for excellence in breast cancer detection technology.